BRUSSELS, September 18
The European Union has agreed to purchase a possible Covid-19 vaccine from Sanofi and GSK in its second such deal to safe provides, as a deadline for signing as much as the WHO’s vaccine buy programme looms.
The deal will see the French and British drugmakers, which have teamed as much as manufacture a recombinant protein-based vaccine they hope to get accepted subsequent yr, present the EU with as much as 300 million doses, based on a tweet from European Health Commissioner Stella Kyriakides. Friday’s settlement confirms an announcement made on July 31 by the 2 corporations and follows an earlier deal between the EU and AstraZeneca for as much as 400 million photographs.
The newest deal comes on deadline day for members of the WHO to hitch its COVAX scheme. “The UK will be co-hosting a virtual vaccines event with the UN, WHO, and South Africa. Building on the success of the UK-hosted Global Vaccine Summit in June, where we collectively raised $8.8 billion, this event will bring together countries and international partners to commit to making sure there is global equitable access to new Covid-19 vaccines, treatments and testing,” UK Foreign Secretary Dominic Raab mentioned earlier this week, throughout a go to to the US.— Reuters